10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,829,791 | -28.8% | 68,601 | -3.6% | 0.01% | -18.2% |
| Q2 2023 | $3,974,468 | -3.6% | 71,176 | -3.7% | 0.01% | -8.3% |
| Q1 2023 | $4,122,769 | +37.5% | 73,898 | -10.2% | 0.01% | +20.0% |
| Q4 2022 | $2,998,247 | +19.0% | 82,279 | -7.0% | 0.01% | +25.0% |
| Q3 2022 | $2,520,000 | -40.7% | 88,468 | -5.8% | 0.01% | -27.3% |
| Q2 2022 | $4,248,000 | -1.4% | 93,884 | +65.7% | 0.01% | +22.2% |
| Q1 2022 | $4,309,000 | -22.3% | 56,645 | +52.1% | 0.01% | -18.2% |
| Q4 2021 | $5,547,000 | +3.6% | 37,237 | +1.2% | 0.01% | 0.0% |
| Q3 2021 | $5,356,000 | -25.8% | 36,791 | -0.2% | 0.01% | -26.7% |
| Q2 2021 | $7,218,000 | -1.5% | 36,862 | -9.0% | 0.02% | -6.2% |
| Q1 2021 | $7,330,000 | +76.3% | 40,497 | +37.9% | 0.02% | +60.0% |
| Q4 2020 | $4,158,000 | +333.1% | 29,367 | +281.4% | 0.01% | +400.0% |
| Q3 2020 | $960,000 | +50.2% | 7,700 | +7.7% | 0.00% | 0.0% |
| Q2 2020 | $639,000 | – | 7,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |